fbpx

Geron Conceals Study Results, Sells Inflated Stock Class Action

Geron Corporation, a biopharmaceutical company, had just one drug in its pipeline, imetelstat. The complaint for this class action alleges that a Phase 2 clinical trial for the drug produced disappointing results. Despite this, according to the complaint, company insiders sold a large amount of stock without disclosing the results of the trial. This class  Read more

Geron Name on Cell and Penny Background

SoClean CPAP Cleaning Devices Produce Ozone Texas Class Action

SoClean, Inc. makes devices to clean continuous positive airway pressure (CPAP) machines. But the complaint for this class action alleges that SoClean uses ozone for cleaning, and that it makes false statements about both this toxic gas and its devices, misrepresenting their potential dangers to humans.  Read more

SoClean 2 CPAP Sanitizing Machine

FCA US Requirements for “Lifetime” Powertrain Warranty Class Action

Two issues are argued in this class action against FCA US, LLC and Olathe Dodge Chrysler Jeep Ram. One is a breach of warranty claim for a “manifold bolt issue.” The other concerns the requirements to maintain a “lifetime” warranty, which the complaint alleges are concealed from customers so they allow the warranty to become  Read more

FCA Dodge Ram Truck

Genworth Viability and Long Term Care Insurance Rate Increases Class Action

“Long Term Care is expensive. So too is Long Term Care Insurance.” So says this class action, which claims that Genworth Financial, Inc. and Genworth Life Insurance Company omitted material information about their long term care (LTC) policies when implementing premium increases.  Read more

Genworth Financial Logo

Endo International Concealed Par Pharmaceuticals Conduct Securities Class Action

Endo International plc develops pharmaceutical products and generic drugs, so its acquisition of Par Pharmaceutical Holdings, Inc., a maker of generic drugs, must have seemed like a profitable move. But the complaint claims Endo concealed information then and over the next many months: that Par had colluded to fix generic drug prices, that the “double-digit  Read more